These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 22018840

  • 1. PDE inhibitors: a new approach to treat metabolic syndrome?
    Lugnier C.
    Curr Opin Pharmacol; 2011 Dec; 11(6):698-706. PubMed ID: 22018840
    [Abstract] [Full Text] [Related]

  • 2. Cyclic nucleotide phosphodiesterases: critical modulators of endocrine, metabolic, and cardiovascular function and appealing therapeutic targets.
    Manganiello V.
    Curr Opin Pharmacol; 2011 Dec; 11(6):646-8. PubMed ID: 22079477
    [No Abstract] [Full Text] [Related]

  • 3. Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment.
    Levy I, Horvath A, Azevedo M, de Alexandre RB, Stratakis CA.
    Curr Opin Pharmacol; 2011 Dec; 11(6):689-97. PubMed ID: 22047791
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ, Cieslinski LB.
    Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
    [Abstract] [Full Text] [Related]

  • 7. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
    Souness JE, Diocee BK, Martin W, Moodie SA.
    Biochem J; 1990 Feb 15; 266(1):127-32. PubMed ID: 2155604
    [Abstract] [Full Text] [Related]

  • 8. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
    Rybalkin SD, Bornfeldt KE.
    Thromb Haemost; 1999 Aug 15; 82(2):424-34. PubMed ID: 10605733
    [No Abstract] [Full Text] [Related]

  • 9. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases.
    Kuo JF, Shoji M, Brackett NL, Helfman DM.
    J Cyclic Nucleotide Res; 1978 Dec 15; 4(6):463-74. PubMed ID: 85641
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P, Prigent AF, Lagarde M, Nemoz G.
    Mol Pharmacol; 1993 Nov 15; 44(5):1027-35. PubMed ID: 8246905
    [Abstract] [Full Text] [Related]

  • 13. Implications of PDE4 structure on inhibitor selectivity across PDE families.
    Ke H.
    Int J Impot Res; 2004 Jun 15; 16 Suppl 1():S24-7. PubMed ID: 15224132
    [Abstract] [Full Text] [Related]

  • 14. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
    Weishaar RE, Quade MM, Schenden JA, Evans DB.
    J Cyclic Nucleotide Protein Phosphor Res; 1985 Jun 15; 10(6):551-64. PubMed ID: 3003170
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phosphodiesterase inhibitors.
    Boswell-Smith V, Spina D, Page CP.
    Br J Pharmacol; 2006 Jan 15; 147 Suppl 1(Suppl 1):S252-7. PubMed ID: 16402111
    [Abstract] [Full Text] [Related]

  • 17. [Separation and investigation of the regulatory properties of two forms of cyclic nucleotide phosphodiesterase from rabbit heart--sensitive and insensitive to Ca-dependent regulator protein].
    Tkachuk VA, Lazarevich VG, Men'shikov MIu, Severin SE.
    Biokhimiia; 1978 Sep 15; 43(9):1622-30. PubMed ID: 214170
    [Abstract] [Full Text] [Related]

  • 18. The isoenzyme selectivity of AH 21-132 as an inhibitor of cyclic nucleotide phosphodiesterase activity.
    Elliott KR, Berry JL, Bate AJ, Foster RW, Small RC.
    J Enzyme Inhib; 1991 Sep 15; 4(3):245-51. PubMed ID: 1645399
    [Abstract] [Full Text] [Related]

  • 19. Isoenzyme-selective cyclic nucleotide phosphodiesterase inhibitors: effects on airways smooth muscle.
    Raeburn D, Advenier C.
    Int J Biochem Cell Biol; 1995 Jan 15; 27(1):29-37. PubMed ID: 7757880
    [Abstract] [Full Text] [Related]

  • 20. Cyclic nucleotide phosphodiesterase in heart and aorta of spontaneously hypertensive rats.
    Sharma RV, Bhalla RC.
    Biochim Biophys Acta; 1978 Oct 12; 526(2):479-88. PubMed ID: 214127
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.